Fungal Infections in People Who Use Drugs

Jose Portugal Gonzales1, Luis Ostrosky-Zeichner1

  • 1Division of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

PubMed

Insights

Illicit drug use is linked to rising fungal infections, including candidemia and mold infections. Drug interactions with antifungals pose serious health risks, including overdose.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Illicit drug use is increasing in the U.S., leading to a rise in associated severe infections.
  • Intravenous drug use is a significant risk factor for candidemia, particularly *Candida albicans* infections.
  • Marijuana and other drug use are linked to increased risks of mold infections (*Aspergillus*, *Mucorales*) and other fungal infections.

Purpose of the Study:

  • To highlight the association between illicit drug use and various fungal infections.
  • To identify the specific fungal species and molds implicated in drug-associated infections.
  • To examine potential drug interactions between commonly used substances and antifungal medications.

Main Methods:

  • Review of surveillance data on candidemia and fungal infections.
  • Analysis of risk factors associated with intravenous drug use and marijuana use.
  • Investigation of metabolic pathways involving illicit drugs, antifungals (triazoles, terbinafine), and CYP enzymes (CYP3A4, CYP2D6).

Main Results:

  • 28%-34% of candidemia cases are linked to intravenous drug use, with *Candida albicans* being most common.
  • Marijuana use increases the risk of mold infections (3.5-fold) and other fungal infections (2.2-fold).
  • Intravenous drug use is a risk factor for *Aspergillus* and *Mucorales* infections.
  • Illicit drugs (cannabis, methamphetamines, opioids) share metabolic pathways with antifungals via CYP enzymes.
  • Antifungal drugs inhibit CYP3A4 and CYP2D6, increasing risks of adverse effects and overdose.

Conclusions:

  • Illicit drug use is a significant driver of serious fungal infections in the U.S.
  • Drug interactions between illicit substances and antifungals present a critical public health concern.
  • Awareness and management of these drug-drug interactions are crucial for patient safety.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
208
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.6K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
10.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
833